Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
31st Mar 2014 2:00 pm RNS Director/PDMR Shareholding
31st Mar 2014 2:00 pm RNS Director/PDMR Shareholding
31st Mar 2014 2:00 pm RNS Director/PDMR Shareholding
26th Mar 2014 11:00 am RNS Director/PDMR Shareholding
21st Mar 2014 7:00 am RNS Filing of Annual Report on Form 20-F with SEC
20th Mar 2014 11:00 am RNS Annual Financial Report
20th Mar 2014 11:00 am RNS Directorate Change
19th Mar 2014 3:00 pm RNS Director/PDMR Shareholding
12th Mar 2014 7:00 am RNS AstraZeneca announces sale of Alderley Park site
3rd Mar 2014 4:00 pm RNS Total Voting Rights
3rd Mar 2014 7:00 am RNS US FDA APPROVES BYDUREON® PEN
25th Feb 2014 6:24 pm RNS FDA Approves Orphan Drug Myalept
12th Feb 2014 3:30 pm RNS Director/PDMR Shareholding
11th Feb 2014 5:00 pm RNS Director/PDMR Shareholding
10th Feb 2014 5:30 pm RNS Director/PDMR Shareholding
7th Feb 2014 3:30 pm RNS Director/PDMR Shareholding
6th Feb 2014 7:00 am RNS Pipeline Table
6th Feb 2014 7:00 am RNS Final Results
5th Feb 2014 9:00 am RNS Notice of Results
3rd Feb 2014 4:30 pm RNS Total Voting Rights
3rd Feb 2014 7:00 am RNS AZ completes BMS diabetes acquisition
27th Jan 2014 10:30 am RNS Holding(s) in Company
22nd Jan 2014 7:00 am RNS Xigduo approved in EU for type 2 diabetes
17th Jan 2014 10:42 am RNS Replacement re block listing application
17th Jan 2014 7:00 am RNS Block Listing Application
14th Jan 2014 7:00 am RNS AstraZeneca provides strategy update at JP Morgan
13th Jan 2014 7:00 am RNS US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN)
9th Jan 2014 7:00 am RNS US FDA Approval of Farxiga (dapagliflozin)
2nd Jan 2014 4:00 pm RNS Total Voting Rights
27th Dec 2013 7:13 am RNS AZ and Shionogi extend Crestor agreement
19th Dec 2013 2:00 pm RNS Director/PDMR Shareholding
19th Dec 2013 7:50 am RNS AZ to acquire BMS share of diabetes assets
17th Dec 2013 6:13 pm RNS STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US
13th Dec 2013 7:14 am RNS Top Line Results From Phase III Study of Lesinurad
13th Dec 2013 7:00 am RNS FDA Advisory Committee Recommends Dapagliflozin
12th Dec 2013 7:00 am RNS FDA Advisory Committee Votes on Metreleptin
6th Dec 2013 7:00 am RNS European Commission Approves Fluenz Tetra
2nd Dec 2013 3:00 pm RNS Blocklisting Interim Review
22nd Nov 2013 1:42 pm RNS XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES
19th Nov 2013 7:00 am RNS NDA for Naloxegol accepted by US FDA
FTSE 100 Latest
Value8,275.66
Change0.00